Cite
Prognosis of patients treated with cART from 36 months after initiation, according to current and previous CD4 cell count and plasma HIV-1 RNA measurements.
MLA
Lanoy, Emilie, et al. “Prognosis of Patients Treated with CART from 36 Months after Initiation, According to Current and Previous CD4 Cell Count and Plasma HIV-1 RNA Measurements.” AIDS (London, England), vol. 23, no. 16, Oct. 2009, pp. 2199–208. EBSCOhost, https://doi.org/10.1097/QAD.0b013e3283305a00.
APA
Lanoy, E., May, M., Mocroft, A., Phillip, A., Justice, A., Chêne, G., Furrer, H., Sterling, T., Monforte, A. D., Force, L., Gill, J., Harris, R., Hogg, R. S., Rockstroh, J., Saag, M., Khaykin, P., de Wolf, F., Sterne, J. A. C., & Costagliola, D. (2009). Prognosis of patients treated with cART from 36 months after initiation, according to current and previous CD4 cell count and plasma HIV-1 RNA measurements. AIDS (London, England), 23(16), 2199–2208. https://doi.org/10.1097/QAD.0b013e3283305a00
Chicago
Lanoy, Emilie, Margaret May, Amanda Mocroft, Andrew Phillip, Amy Justice, Geneviève Chêne, Hansjakob Furrer, et al. 2009. “Prognosis of Patients Treated with CART from 36 Months after Initiation, According to Current and Previous CD4 Cell Count and Plasma HIV-1 RNA Measurements.” AIDS (London, England) 23 (16): 2199–2208. doi:10.1097/QAD.0b013e3283305a00.